You are here

Rick Gonzalez

AbbVie talks next steps as first Humira competitor makes it to market

Endpoints

Thu, 02/9/23 - 06:01 pm

AbbVie's Gonzalez: Skyrizi and Rinvoq to become Humira 2.0 — while adding an indication for atopic dermatitis

Endpoints

Wed, 02/2/22 - 11:46 pm

Even AbbVie CEO can't confirm Rinvoq's sales as FDA mulls JAK label

Fierce Pharma

Mon, 11/1/21 - 10:55 am

Should You Worry About AbbVie Inc.'s (NYSE:ABBV) CEO Pay Check?

Yahoo/Simply Wall St

Wed, 11/6/19 - 10:31 am

Forget Humira -- Here's What You Need to Know About AbbVie

Motley Fool

Sun, 01/27/19 - 12:13 pm

AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs

Endpoints

Fri, 09/22/17 - 09:19 am

AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal

WSJ Online

Fri, 10/31/14 - 02:02 pm

AbbVie CEO Says Humira Will Blunt $1B Hit To Lipid Franchise

Forbes

Wed, 01/30/13 - 10:48 am